Aetna and AstraZeneca Face Accusations of Wrongful Coverage Denial
What happened
A man identified as Justin Dynlacht, who was fired from AstraZeneca, accused both AstraZeneca and Aetna of wrongfully denying him coverage for Crohn’s disease. Dynlacht sent graphic and vulgar messages to executives and employees of both companies over an 18-month period. His complaints against the companies were previously detailed in an April 2024 article in The New York Times regarding patient costs.
From whyy.org
Why it matters
The accusations relate to coverage denial, which is a core function of both Aetna and AstraZeneca. The claims raise potential legal and regulatory exposure for both companies involved in the healthcare market.
From whyy.org
Who's involved
- AetnaAccused of wrongful coverage denial for Crohn’s disease.
- AstraZenecaAccused of wrongful coverage denial and was the former employer of the accuser.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- AetnaSpeculative
Aetna could face increased legal and regulatory costs due to the accusation of wrongful coverage denial.
Keep exploring
The entities involved
-
Aetna
American managed health care company
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- Disputes over increasing coverage denials and payment takebacks involving Aetna, Genesis HealthCare System, and CareSource.
- General Motors switched its health coverage administration to Aetna on October 9, 2026.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.